Destiny Pharma Share Discussion Threads

[t0pgrader] 10/11/2020 12:34

FC's share price target of 301p assumes (1) a 53% probability of XF-73 reaching market and 60% for NTCD-M3 and (2) Zero milestone receipts from licencees.

Since FDA approval and therefore value is largely binary I would prefer to say the upside potential valuation is at least 550p plus whatever milestone payments you think appropriate and excl the cash being raised.

[goblin99] 10/11/2020 11:52

To do with tax relief in essence. If you hold in an ISA already, I do not believe it makes much difference.https://www.pruadviser.co.uk/knowledge-literature/knowledge-library/eis-vct-seis/#

[supracat] 10/11/2020 11:32

That's what I thought but also mention of EIS and VCT shares too so I got a bit confused about it all... will wait to get all the paperwork through.

[goblin99] 10/11/2020 11:25

Is it not a case of offer to existing holders at the open offer price - 65p?

[supracat] 10/11/2020 11:04

Sounds really positive. Not entirely sure why share price is getting hammered today though??. Am waiting to see the terms of the offer for existing shareholders before buying more in open mkt. Destiny feels like a £200m+ company already and still can't believe it's only £30m!!!

[wh1spa] 10/11/2020 10:46

They value the latest acquisition at 57p on its own.

[supracat] 10/11/2020 10:43

Do u have access to their report mate? Woww £3 target.... that's definitely more like where I consider this company is heading, and prob not far from if phase 2b data is relatively positive and their other streams too.

[wh1spa] 10/11/2020 09:31

FinnCap now have a £3.00 target price on DEST.

[supracat] 10/11/2020 08:52

Hi. Am waiting to find out more about the open offer first. ??

[gaiusgracchus] 10/11/2020 08:50

I hope so, but how can you tell it's a decent acquisition? (I can't)

[nico115] 10/11/2020 08:43

Are you buying more down here ?Seems like a decent acquisition.

[supracat] 01/11/2020 09:32

Welcome. I used to live nearby in bishops Cleeve many years ago. ?

[tewkesbury] 01/11/2020 09:30

Good morning.

[supracat] 31/10/2020 12:09

Yep, so under the radar a bit like Novacyt were tbh so hopefully Dest mirror how they've performed.

[wh1spa] 31/10/2020 09:42

I still cant get over how under the radar this is. Normally the advfn, lse etc BB's would be going balistic over this company.

[supracat] 31/10/2020 08:53

It's incredible to see the development and news flow and associated share price movement of Destiny Pharma over the past year. In conjunction with the Spore Gen Joint Venture for a Covid 19 preventative I'm hearing on the grapevine, and would certainly agree, that Destiny Pharma could well emulate, or become, the Novacyt of 2021. Plenty of positive dimensions with this company be it antimicrobials, great pipeline of new antibiotics via the XF series, and the Covid 19 protective nasal spray development with Spore Gen. IMHO, all pointing to a great 2021 and significant rating and share price increase. Judging by recent share price moves upward it would seem that others are already starting to catch on that Destiny could be the next Novacyt. Here's hoping!

[supracat] 26/10/2020 21:09

Yep. Saw this a few weeks ago. Another potential target market for Destiny down the road. Sounds beneficial.

[mikeh30] 26/10/2020 20:37

Yes mate. Not sure how that escaped me. Huge

[wh1spa] 26/10/2020 20:34

you mean this:

01 Oct 2020 – Destiny Pharma welcomes proposed PASTEUR Act in USA
Destiny Pharma welcomes the proposed PASTEUR Act in USA, with financial support ranging from $750 million to $3 billion, to launch new antiinfective products targeting life threatening infections.

thanks mikeh30.
I will sell at £3.00

[mikeh30] 26/10/2020 20:33

A drug developer may apply to HHS for a subscription contract at or within five years following FDA approval. Contracts will range from $750 million to $3 billion and will be paid out over a period of up to 10 years or through the length of patent exclusivity

[mikeh30] 26/10/2020 20:28

Good day today.Supra - I totally missed this:https://www.destinypharma.com/2020/10/01/destiny-pharma-welcomes-proposed-pasteur-act-in-usa/

[t0pgrader] 26/10/2020 13:31

Interesting perspective supracat. Thanks for sharing.

[supracat] 26/10/2020 12:51

Yep. Agree. I've s few buy orders out there waiting for stock from early morning to complete them but no stock coming. Through. This Share price is still totally undervaluing Destiny. 200p alone for where they are with ph2 b trial and the good news from the trials so far. When you layer on spore JV and the volume of nasal sprays for covid in the future then imho this a £4+ share with market cap over the £200m. Would not be surprised if a deal with a large pharma is waiting in the wings at present subject to p2b trial outcomes being relatively positive.

[t0pgrader] 26/10/2020 12:44

Remarkably few sells which suggests we've avoided the momentum traders thus far and the bb is free of the usual scum that attend a share price spike